Arrowhead Pharmaceuticals, Inc. (ARWR) Profit Margin
Arrowhead Pharmaceuticals, Inc. (ARWR) net profit margin by fiscal period. Analyze profit margins in Excel with MarketXLS.
Profit Margin Data
| Period | Net Profit Margin |
|---|---|
| 2016-09-30 | -51614.64% |
| 2017-09-30 | -109.46% |
| 2018-09-30 | -337.32% |
| 2019-09-30 | 40.27% |
| 2020-09-30 | -96.09% |
| 2021-09-30 | -101.85% |
| 2022-09-30 | -72.39% |
| 2023-09-30 | -85.27% |
| 2024-09-30 | -16882.37% |
| 2025-09-30 | -0.20% |
How ARWR compares with sector peers
| Symbol | Company | Net profit margin (latest fiscal year) |
|---|---|---|
| NVAX | Novavax Inc. | 39.19% |
| GILD | Gilead Sciences Inc. | 28.90% |
| EBS | Emergent BioSolutions Inc. | 7.08% |
| ACHV | Achieve Life Sciences Inc. | -24.38% |
| NMTC | NeuroOne Medical Technologies Corporation | -39.63% |
These are five companies in the same sector as ARWR with a comparable annual net profit margin. Each figure above is that company's most recent completed fiscal year, read from the same annual statements as the table on its own page, so the period end dates can differ between rows.
Get Arrowhead Pharmaceuticals, Inc. Data in Excel
Stream real-time stock prices and financials directly into your spreadsheets with MarketXLS.
Try: =hf_Profit_Margin("ARWR", 2024)
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Volume |
| 2 | ARWR | $82.74 | +0.42% | 1.33M |
| 3 | ||||
| 4 | ||||
| 5 |